{
  "case_id": "case_0024",
  "provider": "google",
  "status": "processed",
  "patient_demographics": {
    "age": 45.82,
    "sex": "Female",
    "genderIdentity": "Transgender Male",
    "ancestry": "Middle Eastern / North African"
  },
  "marking_output": {
    "Localisation": {
      "report_string": "--- Localisation ---\n  \nSome more precision is possible than: 'right Optic Nerve'.  \nNamely, in the region of: bilateral optic nerve.\n  \nSome more precision is possible than: 'right Thoracic Spinal Cord'.  \nNamely, in the region of: right T5 spinal cord.",
      "structured_data": {
        "gt_lesions_english": [
          "right T5 myelopathy",
          "bilateral optic nerve (cranial nerve II)"
        ],
        "ft_lesions_parsed": [
          {
            "location": "Optic Nerve",
            "side": "right",
            "qualifier": null
          },
          {
            "location": "Thoracic Spinal Cord",
            "side": "right",
            "qualifier": null
          }
        ],
        "exact_matches": [],
        "imprecise_matches": [
          [
            "right Optic Nerve",
            [
              "bilateral optic nerve (cranial nerve II)"
            ]
          ],
          [
            "right Thoracic Spinal Cord",
            [
              "right T5 myelopathy"
            ]
          ]
        ],
        "missing_lesions_from_ft": [],
        "additional_lesions_in_ft": []
      },
      "scoring": {
        "gt_lesion_count": 2,
        "correctly_identified_count": 0,
        "imprecisely_identified_count": 2,
        "missed_lesion_count": 0,
        "additional_lesion_count": 0,
        "proportion_correct": 0.0,
        "proportion_imprecise": 1.0,
        "proportion_missed": 0.0,
        "proportion_additional": 0.0
      }
    },
    "Differential diagnosis": {
      "report_string": "--- Differential diagnosis ---\nCorrectly included Multiple sclerosis.\n\nAgree to also consider:\n- NMOSD (AQP4+), MOGAD, Neurosarcoid and SLE.\n\nOther possible differentials:\n- Neurosyphilis.\n- Also feasible but of low probability: Lyme, Vasculitis, ADEM and Beh\u00e7et's.\n\nThe following suggested diagnoses have a low probability of providing a unifying explanation for the full clinical presentation:\n- Idiopathic Transverse Myelitis (plausible for unilateral spinal cord; but atypical for bilateral optic nerve involvement)",
      "structured_data": {
        "ft_diagnoses_raw": [
          "Multiple Sclerosis (MS)",
          "Neuromyelitis Optica Spectrum Disorder (NMOSD)",
          "MOG Antibody Disease (MOGAD)",
          "Idiopathic Transverse Myelitis",
          "Neurosarcoidosis",
          "Systemic Lupus Erythematosus (SLE)"
        ],
        "gt_diagnoses_with_source": {
          "Multiple sclerosis": "evaluation"
        },
        "correctly_mentioned_original_gt": [
          "Multiple sclerosis"
        ],
        "missing_original_gt": [],
        "matched_lesion_dx_keys": [
          "AQP4_NMOSD",
          "Neurosarcoidosis",
          "MS",
          "Autoimmune_Myelitis_SLE",
          "MOGAD"
        ],
        "missing_lesion_dx_keys": [
          "Infection_Lyme",
          "Syphilis",
          "CNS_Vasculitis",
          "ADEM",
          "Behcet_Disease"
        ],
        "missing_common_names": [
          "Neurosyphilis"
        ],
        "missing_low_prob_names": [
          "Lyme",
          "Vasculitis",
          "ADEM",
          "Beh\u00e7et's"
        ],
        "additional_diagnoses": [
          "Idiopathic Transverse Myelitis"
        ]
      },
      "scoring": {
        "primary_diagnosis_included": 1,
        "primary_diagnosis_name": "Multiple sclerosis",
        "gt_total_count": 1,
        "gt_matched_count": 1,
        "gt_missed_count": 0,
        "gt_coverage_percentage": 1.0,
        "additional_less_plausible_count": 1,
        "comorbidity_missing_count": 0,
        "other_considerations_missed_count": 0,
        "lesion_ddx_total_count": 10,
        "lesion_ddx_matched_count": 5,
        "lesion_ddx_missed_common_count": 1,
        "lesion_ddx_missed_low_prob_count": 4,
        "lesion_ddx_coverage_percentage": 0.5
      }
    },
    "Investigations": {
      "report_string": "--- Investigations ---\n\n- Agree with the suggested MRI including the Cervical Spine, Brain and Thoracic Spine and CSF test for Oligoclonal Bands - would potentially inform a diagnosis/details of multiple sclerosis.\n\nBut incomplete, should also consider: MRI Orbits.\n\nTo evaluate other differential diagnoses:\n- Agree with considering: anti-dsDNA, anti-MOG, ANA, CRP, ENA, ANCA, anti-AQP4, syphilis, ESR.\n- Could also consider testing: ACE, lyme.",
      "structured_data": {
        "gt_required_tests_primary": [
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Cervical Spine",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Thoracic Spine",
            "condition": "Multiple sclerosis"
          }
        ],
        "ft_proposed_investigations": [
          "MRI Brain and Whole Spine with gadolinium",
          "Aquaporin-4 (AQP4) antibody test",
          "Myelin Oligodendrocyte Glycoprotein (MOG) antibody test",
          "Lumbar Puncture (CSF microscopy, culture, glucose, protein, oligoclonal bands)",
          "Full blood count",
          "Urea and electrolytes",
          "Liver function tests",
          "C-reactive protein",
          "Erythrocyte sedimentation rate",
          "Thyroid function tests",
          "Vitamin B12",
          "Folate",
          "Autoimmune screen (ANA, ENA, dsDNA)",
          "Syphilis serology",
          "HIV serology",
          "Visual Evoked Potentials (VEP)"
        ],
        "all_identified_ft_keys": [
          "Anti_dsDNA",
          "MOG_Antibodies",
          "CRP",
          "Autoimmune_Screen_General",
          "TFT",
          "ENA_Panel",
          "LFT",
          "Vitamin_B12",
          "Glucose_HbA1c",
          "CSF_Oligoclonal_Bands",
          "U_and_E",
          "AQP4_Antibodies",
          "Blood_Cultures",
          "Syphilis_Serology",
          "CSF_General",
          "FBC",
          "ANA",
          "MRI_Whole_Spine",
          "MRI_Lumbosacral_Spine",
          "MRI_Cervical_Spine",
          "Folate",
          "MRI_Thoracic_Spine",
          "ANCA",
          "HIV_Test",
          "VEP",
          "MRI_Brain",
          "ESR"
        ],
        "found_tests_primary": [
          {
            "type": "MRI",
            "region": "Cervical Spine",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Brain",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "MRI",
            "region": "Thoracic Spine",
            "condition": "Multiple sclerosis"
          },
          {
            "type": "CSF",
            "detail": "Oligoclonal Bands",
            "condition": "Multiple sclerosis"
          }
        ],
        "missing_tests_primary": [
          {
            "type": "MRI",
            "region": "Orbits",
            "condition": "Multiple sclerosis"
          }
        ],
        "expected_inv_keys_ddx": [
          "Anti_dsDNA",
          "MOG_Antibodies",
          "ANA",
          "CRP",
          "AQP4_Antibodies",
          "ENA_Panel",
          "Serum_ACE",
          "ANCA",
          "Syphilis_Serology",
          "ESR",
          "Lyme_Serology"
        ],
        "found_inv_keys_ddx": [
          "Anti_dsDNA",
          "MOG_Antibodies",
          "ANA",
          "CRP",
          "ENA_Panel",
          "ANCA",
          "AQP4_Antibodies",
          "Syphilis_Serology",
          "ESR"
        ],
        "missing_inv_keys_ddx": [
          "Serum_ACE",
          "Lyme_Serology"
        ]
      },
      "scoring": {
        "primary_tests_required_count": 5,
        "primary_tests_found_count": 4,
        "primary_tests_missed_count": 1,
        "primary_tests_coverage_percentage": 0.8,
        "ddx_tests_expected_count": 11,
        "ddx_tests_found_count": 9,
        "ddx_tests_coverage_percentage": 0.8181818181818182
      }
    },
    "Management": {
      "report_string": "--- Management ---\nSteroids: Not appropriate to start treatment immediately.\n  \nAdditional factors not mentioned:\n\n- This could be a pseudorelapse (exacerbation of an old deficit) rather than a new acute inflammatory relapse, need further clarity in the history of presenting complaint.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n\nDMTs: Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n  \nAdditional factors not mentioned:\n\n- Need a pregnancy test result.",
      "structured_data": {
        "ft_full_plan_parsed": [
          {
            "treatment": "Intravenous Methylprednisolone",
            "timing": "Start Now",
            "reasons": [
              "To reduce acute inflammation and accelerate recovery from the relapse",
              "Presence of significant neurological deficits (visual acuity loss and gait disturbance)"
            ]
          },
          {
            "treatment": "Gastroprotection (e.g., Omeprazole)",
            "timing": "Start Now",
            "reasons": [
              "Prophylaxis against gastric irritation and ulceration during high-dose steroid therapy"
            ]
          },
          {
            "treatment": "Physiotherapy and Occupational Therapy",
            "timing": "Start Now",
            "reasons": [
              "To assess fall risk and assist with mobility given the unsteady gait and spasticity"
            ]
          },
          {
            "treatment": "Disease Modifying Therapy (e.g., Ocrelizumab, Rituximab)",
            "timing": "Delay",
            "reasons": [
              "Cannot initiate long-term immunotherapy until specific diagnosis (MS vs NMOSD vs MOGAD) is confirmed via MRI and antibody results"
            ]
          }
        ],
        "steroids_evaluation": {
          "ft_plan": {
            "treatment": "Intravenous Methylprednisolone",
            "timing": "Start Now",
            "reasons": [
              "To reduce acute inflammation and accelerate recovery from the relapse",
              "Presence of significant neurological deficits (visual acuity loss and gait disturbance)"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "No indication this isn't an exacerbation of an old deficit/pseudorelapse.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Not appropriate to start treatment immediately.\n  \nAdditional factors not mentioned:\n\n- This could be a pseudorelapse (exacerbation of an old deficit) rather than a new acute inflammatory relapse, need further clarity in the history of presenting complaint.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression."
        },
        "dmt_evaluation": {
          "ft_plan": {
            "treatment": "Disease Modifying Therapy (e.g., Ocrelizumab, Rituximab)",
            "timing": "Delay",
            "reasons": [
              "Cannot initiate long-term immunotherapy until specific diagnosis (MS vs NMOSD vs MOGAD) is confirmed via MRI and antibody results"
            ]
          },
          "gt_plan": {
            "treatment_inappropriate": true,
            "reasons": {
              "missing_information": [
                "Need confirmation of MS diagnosis.",
                "Need a pregnancy test result.",
                "A safety screen for patient-specific comorbidities is required to identify contraindications to immunosuppressive therapy."
              ],
              "contraindications": []
            }
          },
          "evaluation_summary": "Appropriate to consider but delay treatment.\n  \nCorrectly identified the following:\n\n- Need confirmation of MS diagnosis.\n\n- Need to know comorbidities to ensure no contraindications to immunosuppression.\n  \nAdditional factors not mentioned:\n\n- Need a pregnancy test result."
        }
      },
      "scoring": {
        "steroids": {
          "decision_category": "inappropriate_commission",
          "is_unsafe": 1,
          "reasons_total": 2,
          "reasons_acknowledged": 0,
          "reasons_missed": 2,
          "reasons_coverage_percentage": 0.0
        },
        "dmt": {
          "decision_category": "appropriate_caution",
          "is_unsafe": 0,
          "reasons_total": 3,
          "reasons_acknowledged": 2,
          "reasons_missed": 1,
          "reasons_coverage_percentage": 0.6666666666666666
        }
      }
    }
  }
}